Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.

MLA

Kosmidou, Ioanna, et al. “Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.” JACC. Cardiovascular Interventions, vol. 12, no. 16, Aug. 2019, pp. 1580–89. EBSCOhost, https://doi.org/10.1016/j.jcin.2019.06.001.

APA

Kosmidou, I., Liu, Y., Alu, M. C., Liu, M., Madhavan, M., Chakravarty, T., Makkar, R., Thourani, V. H., Biviano, A., Kodali, S., & Leon, M. B. (2019). Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. JACC. Cardiovascular Interventions, 12(16), 1580–1589. https://doi.org/10.1016/j.jcin.2019.06.001

Chicago

Kosmidou, Ioanna, Yangbo Liu, Maria C Alu, Mengdan Liu, Mahesh Madhavan, Tarun Chakravarty, Raj Makkar, et al. 2019. “Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.” JACC. Cardiovascular Interventions 12 (16): 1580–89. doi:10.1016/j.jcin.2019.06.001.